Debbie Rigby rounds up the latest in research news
One-on-one semi-structured interviews were conducted with 20 pharmacy support staff from 4 pharmacies and 33 consumers in pharmacies in Brisbane to describe pharmacy staff responsibilities and explore consumers’ expectations on the sale of complementary medicines in community pharmacies. Consumers described complementary medicine use as a personal health choice, and described a pharmacist’s role in helping to select the right product for the right person, expert product knowledge and maintaining a wide range of good quality stock.
International Journal of Pharmacy Practice 2016.
This short case vignette highlights the clinical decision making process for a 29 year old woman to discuss how she can lose weight and whether there are medications that she can take to aid in weight loss. Treatment options include starting lifestyle modification and medication therapy, and maximising lifestyle modification and nonpharmacologic therapies.
New Engl J Med 2016;375(12):1187-9.
A multicentre prospective cohort study has confirmed that early β blocker use is associated with reduced 30 day mortality in patients with acute myocardial infarction; however discontinuation of β blockers at one year was not associated with higher five year mortality. These findings question the utility of prolonged β blocker treatment after acute myocardial infarction in patients without heart failure or left ventricular dysfunction.
Results of an Australian study evaluating the impact of a web-based training program on community pharmacists’ knowledge and skills associated with chronic kidney disease screening support further development and widespread implementation of the training program. The program included a 60-minute web-based training significantly improved pharmacists knowledge and skills associated with CKD screening in community pharmacy.
International Journal of Clinical Pharmacy 2016;38(5):1080-6.